FONAR Corporation (FONR)
USD 13.8
(1.92%)
USD 13.8
(1.92%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 28.6 Million USD | -7.6% |
| 2023 | 30.95 Million USD | 23.8% |
| 2022 | 25 Million USD | -5.19% |
| 2021 | 26.37 Million USD | -8.23% |
| 2020 | 28.74 Million USD | 36.39% |
| 2019 | 21.07 Million USD | 6.0% |
| 2018 | 19.88 Million USD | -4.82% |
| 2017 | 20.88 Million USD | 3.71% |
| 2016 | 20.14 Million USD | 13.49% |
| 2015 | 17.74 Million USD | -6.38% |
| 2014 | 18.95 Million USD | 22.41% |
| 2013 | 15.48 Million USD | 40.23% |
| 2012 | 11.04 Million USD | 1.63% |
| 2011 | 10.86 Million USD | -31.13% |
| 2010 | 15.77 Million USD | -13.81% |
| 2009 | 18.3 Million USD | -49.34% |
| 2008 | 36.12 Million USD | 12.89% |
| 2007 | 32 Million USD | -10.73% |
| 2006 | 35.85 Million USD | -1.82% |
| 2005 | 36.51 Million USD | 2.36% |
| 2004 | 35.67 Million USD | 0.31% |
| 2003 | 35.56 Million USD | -6.8% |
| 2002 | 38.15 Million USD | 24.33% |
| 2001 | 30.69 Million USD | 7.61% |
| 2000 | 28.52 Million USD | 7.22% |
| 1999 | 26.6 Million USD | 11.3% |
| 1998 | 23.9 Million USD | -20.86% |
| 1997 | 30.2 Million USD | 96.1% |
| 1996 | 15.4 Million USD | 10.0% |
| 1995 | 14 Million USD | 10.24% |
| 1994 | 12.7 Million USD | 9.48% |
| 1993 | 11.6 Million USD | 3.57% |
| 1992 | 11.2 Million USD | 5.66% |
| 1991 | 10.6 Million USD | -9.4% |
| 1990 | 11.7 Million USD | -54.83% |
| 1989 | 25.9 Million USD | 25.73% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 8 Million USD | 33.38% |
| 2024 Q2 | 6 Million USD | -59.55% |
| 2024 Q1 | 14.84 Million USD | 52.07% |
| 2024 Q4 | 9.26 Million USD | 15.67% |
| 2023 Q4 | 9.75 Million USD | 28.78% |
| 2023 FY | 30.95 Million USD | 23.8% |
| 2023 Q1 | 6.68 Million USD | -16.15% |
| 2023 Q2 | 6.94 Million USD | 3.85% |
| 2023 Q3 | 7.57 Million USD | 9.19% |
| 2022 FY | 25 Million USD | -5.19% |
| 2022 Q1 | 5.47 Million USD | -34.14% |
| 2022 Q4 | 7.96 Million USD | 24.1% |
| 2022 Q3 | 6.42 Million USD | 24.94% |
| 2022 Q2 | 5.14 Million USD | -6.14% |
| 2021 Q3 | 6.53 Million USD | 31.58% |
| 2021 FY | 26.37 Million USD | -8.23% |
| 2021 Q1 | 6.56 Million USD | -42.74% |
| 2021 Q2 | 4.96 Million USD | -24.35% |
| 2021 Q4 | 8.31 Million USD | 27.28% |
| 2020 Q4 | 11.46 Million USD | 47.72% |
| 2020 FY | 28.74 Million USD | 36.39% |
| 2020 Q1 | 4.76 Million USD | -34.1% |
| 2020 Q2 | 4.74 Million USD | -0.42% |
| 2020 Q3 | 7.75 Million USD | 63.49% |
| 2019 FY | 21.07 Million USD | 6.0% |
| 2019 Q1 | 4.69 Million USD | -17.96% |
| 2019 Q3 | 4.98 Million USD | 19.83% |
| 2019 Q4 | 7.23 Million USD | 45.08% |
| 2019 Q2 | 4.16 Million USD | -11.41% |
| 2018 Q3 | 6.03 Million USD | 63.44% |
| 2018 Q2 | 3.69 Million USD | -16.64% |
| 2018 FY | 19.88 Million USD | -4.82% |
| 2018 Q4 | 5.72 Million USD | -5.17% |
| 2018 Q1 | 4.43 Million USD | -38.18% |
| 2017 Q4 | 7.16 Million USD | 48.83% |
| 2017 FY | 20.88 Million USD | 3.71% |
| 2017 Q1 | 4.47 Million USD | -33.91% |
| 2017 Q2 | 4.43 Million USD | -1.05% |
| 2017 Q3 | 4.81 Million USD | 8.69% |
| 2016 Q3 | 4.45 Million USD | 4.13% |
| 2016 Q4 | 6.77 Million USD | 51.94% |
| 2016 Q1 | 4.62 Million USD | 16.22% |
| 2016 Q2 | 4.28 Million USD | -7.52% |
| 2016 FY | 20.14 Million USD | 13.49% |
| 2015 Q3 | 4.82 Million USD | 8.35% |
| 2015 Q4 | 3.98 Million USD | -17.51% |
| 2015 FY | 17.74 Million USD | -6.38% |
| 2015 Q2 | 4.45 Million USD | -0.56% |
| 2015 Q1 | 4.48 Million USD | -11.1% |
| 2014 FY | 18.95 Million USD | 22.41% |
| 2014 Q1 | 4.03 Million USD | -24.95% |
| 2014 Q2 | 4.6 Million USD | 13.97% |
| 2014 Q3 | 5.27 Million USD | 14.65% |
| 2014 Q4 | 5.04 Million USD | -4.47% |
| 2013 Q1 | 2.71 Million USD | -14.78% |
| 2013 Q4 | 5.38 Million USD | 22.57% |
| 2013 Q3 | 4.39 Million USD | 46.48% |
| 2013 Q2 | 2.99 Million USD | 10.31% |
| 2013 FY | 15.48 Million USD | 40.23% |
| 2012 Q3 | 2.7 Million USD | 4.27% |
| 2012 Q2 | 2.59 Million USD | 2.0% |
| 2012 Q1 | 2.54 Million USD | -15.31% |
| 2012 FY | 11.04 Million USD | 1.63% |
| 2012 Q4 | 3.18 Million USD | 17.69% |
| 2011 Q3 | 2.69 Million USD | 25.03% |
| 2011 Q4 | 3 Million USD | 11.72% |
| 2011 Q2 | 2.15 Million USD | -28.54% |
| 2011 FY | 10.86 Million USD | -31.13% |
| 2011 Q1 | 3.01 Million USD | -23.06% |
| 2010 Q2 | 4.07 Million USD | -4.52% |
| 2010 Q1 | 4.26 Million USD | -7.32% |
| 2010 FY | 15.77 Million USD | -13.81% |
| 2010 Q4 | 3.91 Million USD | 11.32% |
| 2010 Q3 | 3.51 Million USD | -13.65% |
| 2009 Q4 | 4.6 Million USD | 3.37% |
| 2009 Q2 | 4.94 Million USD | 15.0% |
| 2009 Q3 | 4.45 Million USD | -9.91% |
| 2009 Q1 | 4.29 Million USD | -67.52% |
| 2009 FY | 18.3 Million USD | -49.34% |
| 2008 Q4 | 13.23 Million USD | 154.96% |
| 2008 FY | 36.12 Million USD | 12.89% |
| 2008 Q2 | 7.69 Million USD | 16.28% |
| 2008 Q1 | 6.61 Million USD | -29.49% |
| 2008 Q3 | 5.19 Million USD | -32.51% |
| 2007 FY | 32 Million USD | -10.73% |
| 2007 Q4 | 9.38 Million USD | 26.72% |
| 2007 Q3 | 7.4 Million USD | 1.27% |
| 2007 Q2 | 7.31 Million USD | -7.57% |
| 2007 Q1 | 7.9 Million USD | -15.99% |
| 2006 FY | 35.85 Million USD | -1.82% |
| 2006 Q4 | 9.41 Million USD | 6.23% |
| 2006 Q3 | 8.86 Million USD | 1.34% |
| 2006 Q2 | 8.74 Million USD | -13.05% |
| 2006 Q1 | 10.05 Million USD | 10.46% |
| 2005 Q2 | 9.65 Million USD | 14.11% |
| 2005 FY | 36.51 Million USD | 2.36% |
| 2005 Q4 | 9.1 Million USD | -1.98% |
| 2005 Q1 | 8.46 Million USD | -5.46% |
| 2005 Q3 | 9.28 Million USD | -3.81% |
| 2004 Q4 | 8.95 Million USD | 6.01% |
| 2004 Q1 | 9.25 Million USD | -3.71% |
| 2004 Q2 | 9.01 Million USD | -2.59% |
| 2004 Q3 | 8.44 Million USD | -6.37% |
| 2004 FY | 35.67 Million USD | 0.31% |
| 2003 Q4 | 9.61 Million USD | 2.71% |
| 2003 FY | 35.56 Million USD | -6.8% |
| 2003 Q2 | 8.89 Million USD | 13.58% |
| 2003 Q3 | 9.36 Million USD | 5.22% |
| 2003 Q1 | 7.83 Million USD | -48.11% |
| 2002 Q2 | 7.3 Million USD | -2.63% |
| 2002 FY | 38.15 Million USD | 24.33% |
| 2002 Q4 | 15.09 Million USD | 82.89% |
| 2002 Q3 | 8.25 Million USD | 12.98% |
| 2002 Q1 | 7.5 Million USD | 40.86% |
| 2001 FY | 30.69 Million USD | 7.61% |
| 2001 Q1 | 7.41 Million USD | -9.58% |
| 2001 Q4 | 5.32 Million USD | -45.77% |
| 2001 Q3 | 9.82 Million USD | 30.66% |
| 2001 Q2 | 7.51 Million USD | 1.43% |
| 2000 Q3 | 7.46 Million USD | 11.4% |
| 2000 Q4 | 8.19 Million USD | 9.82% |
| 2000 FY | 28.52 Million USD | 7.22% |
| 2000 Q1 | 6.1 Million USD | -20.78% |
| 2000 Q2 | 6.7 Million USD | 9.84% |
| 1999 Q2 | 6.5 Million USD | 14.04% |
| 1999 Q3 | 6.7 Million USD | 3.08% |
| 1999 Q4 | 7.7 Million USD | 14.93% |
| 1999 Q1 | 5.7 Million USD | -21.92% |
| 1999 FY | 26.6 Million USD | 11.3% |
| 1998 FY | 23.9 Million USD | -20.86% |
| 1998 Q4 | 7.3 Million USD | 15.87% |
| 1998 Q2 | 5.5 Million USD | 17.02% |
| 1998 Q3 | 6.3 Million USD | 14.55% |
| 1998 Q1 | 4.7 Million USD | -73.6% |
| 1997 Q3 | 4.9 Million USD | 16.67% |
| 1997 Q1 | 3.4 Million USD | -30.61% |
| 1997 FY | 30.2 Million USD | 96.1% |
| 1997 Q4 | 17.8 Million USD | 263.27% |
| 1997 Q2 | 4.2 Million USD | 23.53% |
| 1996 Q2 | 3.3 Million USD | 0.0% |
| 1996 Q4 | 4.9 Million USD | 25.64% |
| 1996 FY | 15.4 Million USD | 10.0% |
| 1996 Q1 | 3.3 Million USD | -21.43% |
| 1996 Q3 | 3.9 Million USD | 18.18% |
| 1995 Q2 | 3.2 Million USD | -5.88% |
| 1995 FY | 14 Million USD | 10.24% |
| 1995 Q1 | 3.4 Million USD | -15.0% |
| 1995 Q4 | 4.2 Million USD | 27.27% |
| 1995 Q3 | 3.3 Million USD | 3.13% |
| 1994 Q4 | 4 Million USD | 37.93% |
| 1994 FY | 12.7 Million USD | 9.48% |
| 1994 Q3 | 2.9 Million USD | -14.71% |
| 1994 Q2 | 3.4 Million USD | 21.43% |
| 1994 Q1 | 2.8 Million USD | 0.0% |
| 1993 FY | 11.6 Million USD | 3.57% |
| 1993 Q4 | 2.8 Million USD | -15.15% |
| 1993 Q2 | 3 Million USD | 15.38% |
| 1993 Q3 | 3.3 Million USD | 10.0% |
| 1993 Q1 | 2.6 Million USD | 18.18% |
| 1992 FY | 11.2 Million USD | 5.66% |
| 1992 Q1 | 3.1 Million USD | 118.24% |
| 1992 Q2 | - USD | -100.0% |
| 1992 Q3 | 2.8 Million USD | 0.0% |
| 1992 Q4 | 2.2 Million USD | -21.43% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q1 | - USD | 100.0% |
| 1991 Q4 | -17 Million USD | 0.0% |
| 1991 FY | 10.6 Million USD | -9.4% |
| 1991 Q3 | - USD | 0.0% |
| 1990 FY | 11.7 Million USD | -54.83% |
| 1990 Q1 | - USD | 100.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 Q4 | -27.7 Million USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 FY | 25.9 Million USD | 25.73% |
| 1989 Q4 | -56.1 Million USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -154.853% |
| Cerus Corporation | 143.15 Million USD | 80.018% |
| OrthoPediatrics Corp. | 137.01 Million USD | 79.124% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -151.783% |
| Talis Biomedical Corporation | 67.18 Million USD | 57.425% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -14.666% |
| Inogen, Inc. | 236.08 Million USD | 87.884% |
| Spectral AI, Inc. | 20.86 Million USD | -37.101% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 48.917% |
| CVRx, Inc. | 76.14 Million USD | 62.432% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -710.791% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -129.039% |
| Orthofix Medical Inc. | 667.42 Million USD | 95.714% |
| Venus Concept Inc. | 80.47 Million USD | 64.456% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 49.442% |
| Bioventus Inc. | 409.91 Million USD | 93.022% |
| BrainsWay Ltd. | 28.01 Million USD | -2.094% |
| Envoy Medical, Inc. | 17.89 Million USD | -59.821% |
| electroCore, Inc. | 32.03 Million USD | 10.697% |
| IceCure Medical Ltd | 16.87 Million USD | -69.499% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 32.587% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -62.222% |
| MaxCyte, Inc. | 84.84 Million USD | 66.286% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -130.464% |
| Nexalin Technology, Inc. | 5.78 Million USD | -394.775% |
| PAVmed Inc | 64.82 Million USD | 55.875% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 43.998% |
| RxSight, Inc. | 103.85 Million USD | 72.456% |
| Sight Sciences, Inc. | 126.44 Million USD | 77.378% |
| SI-BONE, Inc. | 156.35 Million USD | 81.705% |
| TELA Bio, Inc. | 84.18 Million USD | 66.022% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 59.169% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 85.934% |
| LivaNova PLC | 843.54 Million USD | 96.609% |
| 908 Devices Inc. | 68.08 Million USD | 57.984% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 94.085% |
| Nemaura Medical Inc. | 7.13 Million USD | -300.693% |
| NeuroPace, Inc. | 75.29 Million USD | 62.01% |
| LENSAR, Inc. | 33.33 Million USD | 14.193% |
| Apyx Medical Corporation | 51.01 Million USD | 43.932% |
| Cutera, Inc. | 197.72 Million USD | 85.533% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -15.43% |
| BioSig Technologies, Inc. | 28.53 Million USD | -0.262% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 85.061% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 20.675% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 96.58% |
| Axonics, Inc. | 270.2 Million USD | 89.414% |
| Outset Medical, Inc. | 198.77 Million USD | 85.609% |
| IRIDEX Corporation | 31.81 Million USD | 10.088% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 84.128% |
| IRadimed Corporation | 30.12 Million USD | 5.04% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -235.263% |
| INVO Bioscience, Inc. | 7.85 Million USD | -264.238% |
| Telesis Bio, Inc. | 63.48 Million USD | 54.945% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 70.946% |
| Varex Imaging Corporation | 224.8 Million USD | 87.275% |
| Quipt Home Medical Corp. | 148.66 Million USD | 80.759% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -144.005% |
| Pulmonx Corporation | 112.68 Million USD | 74.616% |
| Dynatronics Corporation | 9.9 Million USD | -188.702% |
| Modular Medical, Inc. | 17.52 Million USD | -63.185% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -41.699% |
| Semler Scientific, Inc. | 38.94 Million USD | 26.549% |
| InMode Ltd. | 215.68 Million USD | 86.737% |
| Bruker Corporation | 1.07 Billion USD | 97.343% |
| Cytosorbents Corporation | 48.33 Million USD | 40.822% |
| DexCom, Inc. | 1.69 Billion USD | 98.309% |
| Align Technology, Inc. | 2.07 Billion USD | 98.623% |
| Viveve Medical, Inc. | 22.17 Million USD | -29.007% |
| ZimVie Inc. | 275.12 Million USD | 89.603% |
| Movano Inc. | 29.69 Million USD | 3.656% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 79.162% |
| Nexalin Technology, Inc. | 5.78 Million USD | -394.775% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -710.791% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 95.24% |
| Profound Medical Corp. | 33.6 Million USD | 14.875% |
| Insulet Corporation | 939.9 Million USD | 96.957% |
| enVVeno Medical Corporation | 25.23 Million USD | -13.34% |
| Surmodics, Inc. | 98.69 Million USD | 71.018% |
| iCAD, Inc. | 22.22 Million USD | -28.705% |
| Nuwellis, Inc. | 22.61 Million USD | -26.497% |
| Biotricity, Inc. | 17.18 Million USD | -66.456% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 93.585% |
| Aethlon Medical, Inc. | 12.27 Million USD | -132.984% |
| InspireMD, Inc. | 22.95 Million USD | -24.639% |
| PAVmed Inc. | 64.82 Million USD | 55.875% |
| BIOLASE, Inc. | 34.66 Million USD | 17.473% |
| Beyond Air, Inc. | 61.7 Million USD | 53.639% |
| AxoGen, Inc. | 149.33 Million USD | 80.845% |
| Vivani Medical, Inc. | 26.96 Million USD | -6.081% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 83.848% |
| Inari Medical, Inc. | 448.59 Million USD | 93.624% |
| UFP Technologies, Inc. | 58.08 Million USD | 50.757% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -480.499% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -352.728% |
| Tenon Medical, Inc. | 16.96 Million USD | -68.58% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -286.916% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 35.141% |
| AdaptHealth Corp. | 1.07 Billion USD | 97.346% |
| Sintx Technologies, Inc. | 15.2 Million USD | -88.176% |
| NanoVibronix, Inc. | 4.97 Million USD | -475.2% |
| Quanterix Corporation | 118.1 Million USD | 75.779% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -144.005% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -98.066% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 92.715% |
| TransMedics Group, Inc. | 182.82 Million USD | 84.354% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -1.923% |
| NeuroMetrix, Inc. | 11.09 Million USD | -157.725% |
| Hyperfine, Inc. | 52.87 Million USD | 45.898% |
| Establishment Labs Holdings Inc. | 172 Million USD | 83.37% |
| Biomerica, Inc. | 6.97 Million USD | -309.927% |
| Bone Biologics Corporation | 9.42 Million USD | -203.392% |
| AVITA Medical, Inc. | 80.77 Million USD | 64.589% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -177.413% |
| Silk Road Medical, Inc | 186.35 Million USD | 84.651% |